Shah Alam Khan (Shah A Khan)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Aqueous Solution

Oxidative Stress

Top Venues

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Dhanalekshmi Unnikrishnan Meenakshi, Gurpreet Kaur Narde, Alka Ahuja, Khalid Al Balushi, Thiyagarajan Devasena, Shah Alam Khan
Therapeutic Applications of Nanoformulated Resveratrol and Quercetin Phytochemicals in Colorectal Cancer-An Updated Review. Pharmaceutics 16 (6) (2024)
Dhanalekshmi Unnikrishnan Meenakshi, Gurpreet Kaur Narde, Alka Ahuja, Khalid Al Balushi, Thiyagarajan Devasena, Shah Alam Khan
Therapeutic Applications of Nanoformulated Resveratrol and Quercetin Phytochemicals in Colorectal Cancer-An Updated Review. Pharmaceutics 16 (6) (2024)
Urvashee Gogoi, Neelutpal Gogoi, Sanchaita Rajkhowa, Shah Alam Khan, Nisreen D Omer, Nawal Al-Hoshani, Samia T Al-Shouli, Aparoop Das
Expanding the therapeutic arsenal against cancer: a computational investigation of hybrid xanthone derivatives as selective Topoisomerase 2α ATPase inhibitors. Journal of biomolecular structure & dynamics (2023)
Aftab Ahmad, Unnikrishnan Meenakshi Dhanalekshmi, Kailasam Koumaravelu, Thiyagarajan Devasena, Shah Alam Khan, Mohammed F Abuzinadah, Nandakumar Selvasudha
A Study on Pharmacokinetic Functionalities and Safety Margins of an Optimized Simvastatin Nanoformulation. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Thiyagarajan Devasena, Aftab Ahmad, Sri Durga Devi Nagarajan, Harish Sundar Yogeeswarakannan, Krishnaraj Sekar, Shah Alam Khan, Dhanalekshmi Unnikrishnan Meenakshi, Asif Husain, Mohammed A Bazuhair, Nandakumar Selvasudha
Development of a Novel Red Clay-Based Drug Delivery Carrier to Improve the Therapeutic Efficacy of Acyclovir in the Treatment of Skin Cancer. Pharmaceutics 15 (7) (2023)
Shah Alam Khan, Mohammad Jawaid Akhtar, Urvashee Gogoi, Dhanalekshmi Unnikrishnan Meenakshi, Aparoop Das
An Overview of 1,2,3-triazole-Containing Hybrids and Their Potential Anticholinesterase Activities. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Aftab Ahmad, Unnikrishnan Meenakshi Dhanalekshmi, Kailasam Koumaravelu, Thiyagarajan Devasena, Shah Alam Khan, Mohammed F Abuzinadah, Nandakumar Selvasudha
A Study on Pharmacokinetic Functionalities and Safety Margins of an Optimized Simvastatin Nanoformulation. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Aftab Ahmad, Unnikrishnan Meenakshi Dhanalekshmi, Kailasam Koumaravelu, Thiyagarajan Devasena, Shah Alam Khan, Mohammed F Abuzinadah, Nandakumar Selvasudha
A Study on Pharmacokinetic Functionalities and Safety Margins of an Optimized Simvastatin Nanoformulation. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Mohd Imran, Mandeep Kumar Arora, Anurag Chaudhary, Shah Alam Khan, Mehnaz Kamal, Manal Mutlaq Alshammari, Raghad Mohammad Alharbi, Nuha Abdullah Althomali, Ibrahim Mohammed Alzimam, Abdullah Ayed Alshammari, Bashair Hamed Alharbi, Amer Mohammad Alshengeti, Abdulmonem A Alsaleh, Shayea A Alqahtani, Ali A Rabaan
MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature. Biomedicines 10 (11) (2022)
Mohd Imran, Shah Alam Khan, Abida Khan, Mohammed Kanan Alshammari, Saif M Alkhaldi, Fayez Nafea Alshammari, Mehnaz Kamal, Ozair Alam, Syed Mohammed Basheeruddin Asdaq, A Khuzaim Alzahrani, Shahamah Jomah
Nigella sativa L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature. Molecules (Basel, Switzerland) 27 (9) (2022)
Namy George, Majed AbuKhader, Khalid Al Balushi, Bushra Al Sabahi, Shah Alam Khan
An insight into the neuroprotective effects and molecular targets of pomegranate ( Punica granatum ) against Alzheimer's disease. Nutritional neuroscience (2022)
Mohd Imran, Shah Alam Khan, Mohammed Kanan Alshammari, Ashwaq Muiedh Alqahtani, Turkiah Abdullah Alanazi, Mehnaz Kamal, Talha Jawaid, Mohammed M Ghoneim, Sultan M Alshehri, Faiyaz Shakeel
Discovery, Development, Inventions and Patent Review of Fexinidazole: The First All-Oral Therapy for Human African Trypanosomiasis. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Khalid Saad Alharbi, Muhammad Afzal, Sami I Alzarea, Shah Alam Khan, Fadhel Ahmed Alomar, Imran Kazmi
Rosinidin Protects Streptozotocin-Induced Memory Impairment-Activated Neurotoxicity by Suppressing Oxidative Stress and Inflammatory Mediators in Rats. Medicina (Kaunas, Lithuania) 58 (8) (2022)
Syed Najmul Hejaz Azmi, Wafa Mustafa Al Lawati, Umaima Hamed Abdullah Al Hoqani, Ekhlas Al Aufi, Khalsa Al Hatmi, Jumana Salim Al Zadjali, Nafisur Rahman, Mohd Nasir, Habibur Rahman, Shah Alam Khan
Development of a Citric-Acid-Modified Cellulose Adsorbent Derived from Moringa peregrina Leaf for Adsorptive Removal of Citalopram HBr in Aqueous Solutions. Pharmaceuticals (Basel, Switzerland) 15 (6) (2022)
Teeba Athar, K Al Balushi, Shah Alam Khan
Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease. Molecular biology reports 48 (7) (2021)
Mohd Imran, Mandeep Kumar Arora, Syed Mohammed Basheeruddin Asdaq, Shah Alam Khan, Saleh I Alaqel, Mohammed Kanan Alshammari, Mohammed Mansour Alshehri, Ahmed Subeh Alshrari, Alreshidi Mateq Ali, Ahmed Muteb Al-Shammeri, Bushra Dhuhayyan Alhazmi, Aishah Ali Harshan, Md Tauquir Alam, Abida Khan
Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19. Molecules (Basel, Switzerland) 26 (19) (2021)
Mohd Imran, Syed Mohammed Basheeruddin Asdaq, Shah Alam Khan, Dhanalekshmi Unnikrishnan Meenakshi, Abdulhakeem S Alamri, Walaa F Alsanie, Majid Alhomrani, Yahya Mohzari, Ahmed Alrashed, Mohammed AlMotairi, Eman H Alkhaldi, Abeer K Alorabi, Ahmed Subeh Alshrari, Mohammad Tauseef, Abida Khan, Saleh I Alaqel, Ozair Alam, Mohammed Afroz Bakht
Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)
Mohd Imran, Shah Alam Khan, Mohammed Kanan Alshammari, Meshal Ayedh Alreshidi, Abeer Abdullah Alreshidi, Rawan Sulaiman Alghonaim, Fayez Aboud Alanazi, Sultan M Alshehri, Mohammed M Ghoneim, Faiyaz Shakeel
Discovery, Development, Inventions, and Patent Trends on Mobocertinib Succinate: The First-in-Class Oral Treatment for NSCLC with EGFR Exon 20 Insertions. Biomedicines 9 (12) (2021)